Skip to content

4/AAccepted Nov 24, 7:37 PM ET

Bausch Christoph Lawrence 4/A

SABSSAB Biotherapeutics, Inc.

Accepted (ET)

7:37 PM

Nov 24, 2021

Filed

Nov 24, 2021

Documents

1

Size

12.7 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.